MetaCap

Immunic Statistics

NASDAQ: IMUXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.99-0.40 (-5.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Immunic by the numbers

Immunic has a market capitalization of $111.0 million based on 15.88M shares outstanding. With trailing EPS of $-3.53, Immunic is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.8% below its 50-day average and 39.7% below its 200-day average.

Average daily trading volume is 343.44K shares, or about $2.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IMUX valuation vs. peer median

IMUX compared with the median of 8 peer companies
MetricIMUXPeer medianDifference
Market cap$111.01M$108.89M+2%
Avg. volume343.44K334.55K+3%

Peer median across 8 companies: OKUR, MENS, SPRB, BGM, AKBA, ADAG, GNLX, FHTX.

Valuation

Price and trading

Previous close
7.39
Open
7.31
Day range
6.97 – 7.56
52-week range
5.06 – 17.43
52-week change
+1.90%
Beta
—
Volume
295.91K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
111.01M
Forward Pe
-2.93
Eps
-3.53
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.43
Week52 Low
5.06
Avg Volume
343.44K
Shares Outstanding
15.88M
Ma50
8.20
Ma200
11.59
Earnings Date
Nov 13, 2026
Pct From52w High
-59.90%
Pct From52w Low
38.14%

Related